|
1
|
Merritt MA, Rice MS, Barnard ME, Hankinson
SE, Matulonis UA, Poole EM and Tworoger SS: Pre-diagnosis and
post-diagnosis use of common analgesics and ovarian cancer
prognosis (NHS/NHSII): A cohort study. Lancet Oncol. 19:1107–1116.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Liu J and Matulonis UA: New strategies in
ovarian cancer: Translating the molecular complexity of ovarian
cancer into treatment advances. Clin Cancer Res. 20:5150–5156.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
du Bois A, Kristensen G, Ray-Coquard I,
Reuss A, Pignata S, Colombo N, Denison U, Vergote I, Del Campo JM,
Ottevanger P, et al: Standard first-line chemotherapy with or
without nintedanib for advanced ovarian cancer (AGO-OVAR 12): A
randomised, double-blind, placebo-controlled phase 3 trial. Lancet
Oncol. 17:78–89. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Majidi A, Na R, Dixon-Suen S, Jordan SJ
and Webb PM: Common medications and survival in women with ovarian
cancer: A systematic review and meta-analysis. Gynecol Oncol.
157:678–685. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van der Hel OL, Timmermans M, van Altena
AM, Kruitwagen RFPM, Slangen BFM, Sonke GS, van de Vijver KK and
van der Aa MA: Overview of non-epithelial ovarian tumours:
Incidence and survival in the Netherlands, 1989–2015. Eur J Cancer.
118:97–104. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zierhut C, Yamaguchi N, Paredes M, Luo JD,
Carroll T and Funabiki H: The cytoplasmic DNA sensor cGAS promotes
mitotic cell death. Cell. 178:302–315.e23. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Koshiyama M, Matsumura N, Imai S, Yamanoi
K, Abiko K, Yoshioka Y, Yamaguchi K, Hamanishi J, Baba T and
Konishi I: Combination of aprepitant, azasetron, and dexamethasone
as antiemetic prophylaxis in women with gynecologic cancers
receiving paclitaxel/carboplatin therapy. Med Sci Monit.
23:826–833. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ren F, Shen J, Shi H, Hornicek FJ, Kan Q
and Duan Z: Novel mechanisms and approaches to overcome multidrug
resistance in the treatment of ovarian cancer. Biochim Biophys
Acta. 1866:266–275. 2016.PubMed/NCBI
|
|
9
|
Li Z, He X, Liu F, Wang J and Feng J: A
review of polysaccharides from Schisandra chinensis and
Schisandra sphenanthera: Properties, functions and
applications. Carbohydr Polym. 184:178–190. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lv XJ, Zhao LJ, Hao YQ, Su ZZ, Li JY, Du
YW and Zhang J: Schisandrin B inhibits the proliferation of human
lung adenocarcinoma A549 cells by inducing cycle arrest and
apoptosis. Int J Clin Exp Med. 8:6926–6936. 2015.PubMed/NCBI
|
|
11
|
Xu Y, Liu Z, Sun J, Pan Q, Sun F, Yan Z
and Hu X: Schisandrin B prevents doxorubicin-induced chronic
cardiotoxicity and enhances its anticancer activity in vivo. PLoS
One. 6:e283352011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen Y, Shi S, Wang H, Li N, Su J, Chou G
and Wang S: A Homogeneous polysaccharide from fructus Schisandra
chinensis (Turz.) baill induces mitochondrial apoptosis through
the Hsp90/AKT signalling pathway in HepG2 cells. Int J Mol Sci.
17:10152016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chun JN, Cho M, So I and Jeon JH: The
protective effects of Schisandra chinensis fruit extract and
its lignans against cardiovascular disease: A review of the
molecular mechanisms. Fitoterapia. 97:224–233. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wan CK, Zhu GY, Shen XL, Chattopadhyay A,
Dey S and Fong WF: Gomisin A alters substrate interaction and
reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR
cells. Biochem Pharmacol. 72:824–837. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Young Park J, Wook Yun J, Whan Choi Y, Ung
Bae J, Won Seo K, Jin Lee S, Youn Park S, Whan Hong K and Kim CD:
Antihypertensive effect of gomisin A from Schisandra
chinensis on angiotensin II-induced hypertension via
preservation of nitric oxide bioavailability. Hypertens Res.
35:928–934. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qu HM, Liu SJ and Zhang CY: Antitumor and
antiangiogenic activity of Schisandra chinensis
polysaccharide in a renal cell carcinoma model. Int J Biol
Macromol. 66:52–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Han YH, Mun JG, Jeon HD, Park J, Kee JY
and Hong SH: Gomisin A ameliorates metastatic melanoma by
inhibiting AMPK and ERK/JNK-mediated cell survival and metastatic
phenotypes. Phytomedicine. 68:1531472020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kee JY, Han YH, Mun JG, Park SH, Jeon HD
and Hong SH: Gomisin A suppresses colorectal lung metastasis by
inducing AMPK/p38-mediated apoptosis and decreasing metastatic
abilities of colorectal cancer cells. Front Pharmacol. 9:9862018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Alexandre J, Hu Y, Lu W, Pelicano H and
Huang P: Novel action of paclitaxel against cancer cells: Bystander
effect mediated by reactive oxygen species. Cancer Res.
67:3512–3517. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
de Sá Junior PL, Câmara DAD, Porcacchia
AS, Fonseca PMM, Jorge SD, Araldi RP and Ferreira AK: The roles of
ROS in cancer heterogeneity and therapy. Oxid Med Cell Longev.
2017:24679402017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Harris IS and DeNicola GM: The complex
interplay between antioxidants and ROS in cancer. Trends Cell Biol.
30:440–451. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Prasad S, Gupta SC and Tyagi AK: Reactive
oxygen species (ROS) and cancer: Role of antioxidative
nutraceuticals. Cancer Lett. 387:95–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chen J, Liu J, Wu S, Liu W, Xia Y, Zhao J,
Yang Y, Wang Y, Peng Y and Zhao S: Atrazine promoted epithelial
ovarian cancer cells proliferation and metastasis by inducing low
dose reactive oxygen species (ROS). Iran J Biotechnol.
19:e26232021.PubMed/NCBI
|
|
24
|
Chen J, Xia Y, Peng Y, Wu S, Liu W, Zhang
H, Wang T, Yang Z, Zhao S and Zhao L: Analysis of the association
between KIN17 expression and the clinical features/prognosis of
epithelial ovarian cancer, and the effects of KIN17 in SKOV3 cells.
Oncol Lett. 21:4752021. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zeng Z, Wang Q, Yang X, Ren Y, Jiao S, Zhu
Q, Guo D, Xia K, Wang Y, Li C and Wang W: Qishen granule attenuates
cardiac fibrosis by regulating TGF-β/Smad3 and GSK-3β pathway.
Phytomedicine. 62:1529492019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takanche JS, Kim JE, Han SH and Yi HK:
Effect of gomisin A on osteoblast differentiation in high
glucose-mediated oxidative stress. Phytomedicine. 66:1531072020.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Goel S, DeCristo MJ, Watt AC, BrinJones H,
Sceneay J, Li BB, Khan N, Ubellacker JM, Xie S, Metzger-Filho O, et
al: CDK4/6 inhibition triggers anti-tumour immunity. Nature.
548:471–475. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jiang B, Ni H, Zhou Z and Li Y: Parkin
enhances sensitivity of paclitaxel to NPC by arresting cell cycle.
Pathol Res Pract. 216:1527552020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ahn JH, Lee HS, Lee JS, Lee YS, Park JL,
Kim SY, Hwang JA, Kunkeaw N, Jung SY, Kim TJ, et al: nc886 is
induced by TGF-β and suppresses the microRNA pathway in ovarian
cancer. Nat Commun. 9:11662018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han YH, Kee JY and Hong SH: Gomisin A
alleviates obesity by regulating the phenotypic switch between
white and brown adipocytes. Am J Chin Med. 49:1929–1948. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hao LJ, Lin RA, Chen LC, Wang JL, Chen IS,
Kuo CC, Chou CT, Chien JM and Jan CR: Action of the natural
compound gomisin a on Ca2+ movement in human prostate
cancer cells. Chin J Physiol. 65:151–157. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
da Cunha Santos G, Shepherd FA and Tsao
MS: EGFR mutations and lung cancer. Annu Rev Pathol. 6:49–69. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Talukdar S, Emdad L, Das SK and Fisher PB:
EGFR: An essential receptor tyrosine kinase-regulator of cancer
stem cells. Adv Cancer Res. 147:161–188. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ko YH, Jeong M, Jang DS and Choi JH:
Gomisin L1, a lignan isolated from Schisandra berries,
induces apoptosis by regulating NADPH oxidase in human ovarian
cancer cells. Life (Basel). 11:8582021.PubMed/NCBI
|
|
35
|
Kretzmann NA, Chiela E, Matte U, Marroni N
and Marroni CA: N-acetylcysteine improves antitumoural response of
Interferon alpha by NF-kB downregulation in liver cancer cells.
Comp Hepatol. 11:42012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu B, Huang X, Li Y, Liao W, Li M, Liu Y,
He R, Feng D, Zhu R and Kurihara H: JS-K, a nitric oxide donor,
induces autophagy as a complementary mechanism inhibiting ovarian
cancer. BMC Cancer. 19:6452019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mendes S, Sá R, Magalhães M, Marques F,
Sousa M and Silva E: The role of ROS as a double-edged sword in
(In)Fertility: The impact of cancer treatment. Cancers (Basel).
14:15852022. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Okon IS and Zou MH: Mitochondrial ROS and
cancer drug resistance: Implications for therapy. Pharmacol Res.
100:170–174. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ma N, Liu P, He N, Gu N, Wu FG and Chen Z:
Action of gold nanospikes-based nanoradiosensitizers: Cellular
internalization, radiotherapy, and autophagy. ACS Appl Mater
Interfaces. 9:31526–31542. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao F, Gao Y, Chu X, Chen J, Huang L,
Zhao J, Zhang J and Zhao S: ROS attenuates the antitumor effect of
Raddeanin on ovarian cancer cells Skov3. Int J Clin Exp Pathol.
10:8292–8302. 2017.PubMed/NCBI
|
|
41
|
Wong RS: Apoptosis in cancer: From
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jiang S, Zhang E, Ruan H, Ma J, Zhao X,
Zhu Y, Xie X, Han N, Li J, Zhang H, et al: Actinomycin V induces
apoptosis associated with mitochondrial and PI3K/AKT pathways in
human CRC cells. Mar Drugs. 19:5992021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang TH, Wang HS and Soong YK:
Paclitaxel-induced cell death: Where the cell cycle and apoptosis
come together. Cancer. 88:2619–2628. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang CC, Li CG, Wang YF, Xu LH, He XH,
Zeng QZ, Zeng CY, Mai FY, Hu B and Ouyang DY: Chemotherapeutic
paclitaxel and cisplatin differentially induce pyroptosis in A549
lung cancer cells via caspase-3/GSDME activation. Apoptosis.
24:312–325. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Manfredi JJ and Horwitz SB: Taxol: An
antimitotic agent with a new mechanism of action. Pharmacol Ther.
25:83–125. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhuang Y, Wu H, Wang X, He J, He S and Yin
Y: Resveratrol attenuates oxidative stress-induced intestinal
barrier injury through PI3K/Akt-mediated Nrf2 signaling pathway.
Oxid Med Cell Longev. 2019:75918402019. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hao Y, Li Y, Liu J, Wang Z, Gao B, Zhang Y
and Wang J: Protective effect of Chrysanthemum morifolium
cv. Fubaiju hot-water extracts against ARPE-19 cell oxidative
damage by activating PI3K/Akt-mediated Nrf2/HO-1 signaling pathway.
Front Nutr. 8:6489732021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ren Y, Geng R, Lu Q, Tan X, Rao R, Zhou H,
Yang X and Liu W: Involvement of TGF-β and ROS in G1 cell cycle
arrest induced by titanium dioxide nanoparticles under UVA
irradiation in a 3D spheroid model. Int J Nanomedicine.
15:1997–2010. 2020. View Article : Google Scholar : PubMed/NCBI
|
